Gadofosveset for Axillary Staging in Breast Cancer Patients
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The aim of this pilot-study is to examine the accuracy of gadofosveset enhanced MRI compared
to current nodal staging methods.
The accuracy of MRL will be determined on the basis of a node-to-node matching of imaged
nodes to the definitive histopathology. The pathologic examination of the SNLB or ALND will
be regarded as the golden standard for nodal involvement.